AVI-4773 and related MPro inhibitors outperform existing treatments like nirmatrelvir in preclinical studies, offering a promising path toward pan-coronavirus therapies. Study: Structure-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback